FMO5 Antikörper (N-Term)
Kurzübersicht für FMO5 Antikörper (N-Term) (ABIN3030971)
Target
Alle FMO5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- FMO5 Antibody
-
Sequenz
- DHYPNFMHNA QVLE
-
Aufreinigung
- Antigen affinity
-
Immunogen
- An amino acid sequence from the N-terminus of human FMO5 (DHYPNFMHNAQVLE) was used as the immunogen for this FMO5 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting amounts. Titration of the FMO5 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the FMO5 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- FMO5 (Flavin Containing Monooxygenase 5 (FMO5))
-
Andere Bezeichnung
- FMO5
-
Hintergrund
- Dimethylaniline monooxygenase [N-oxide-forming] 5 is an enzyme that in humans is encoded by the FMO5 gene. By fluorescence in situ hybridization, this gene was assigned to human chromosome 1q21.1. FMO5 is not an efficient drug-metabolizing enzyme and that it may have an alternative physiologic role. FMO5 transcripts play an important role in progesterone-regulated in breast cancer cells specifically under the control of the progesterone receptor B-isoform.
-
UniProt
- P49326
Target
-